William Enright
2022
In 2022, William Enright earned a total compensation of $2.1M as Chief Executive Officer at Barinthus Biotherapeutics plc., a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $291,135 |
|---|---|
| Option Awards | $1,168,780 |
| Salary | $569,178 |
| Other | $56,306 |
| Total | $2,085,399 |
Enright received $1.2M in option awards, accounting for 56% of the total pay in 2022.
Enright also received $291.1K in non-equity incentive plan, $569.2K in salary and $56.3K in other compensation.
Rankings
In 2022, William Enright's compensation ranked 1,698th out of 5,756 executives tracked by ExecPay. In other words, Enright earned more than 70.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,698 out of 5,756 | 71st |
Division Manufacturing | 888 out of 3,133 | 72nd |
Major group Chemicals And Allied Products | 358 out of 1,419 | 75th |
Industry group Drugs | 327 out of 1,320 | 75th |
Industry Pharmaceutical Preparations | 233 out of 966 | 76th |
Source: SEC filing on March 29, 2023.
Enright's colleagues
We found three more compensation records of executives who worked with William Enright at Barinthus Biotherapeutics plc. in 2022.